Cancer Clinical Trials Office Blog

News & Updates from the CCTO

SRC Protocol Statement of Support (PSOS) Forms Update

-

Both Initial and Renewal PSOS forms have now been updated to include two additional questions:

  1. Has PI completed Annual Clinical Research training?
  2. Does PI have any overdue clinical trials.gov reporting?

Since we have received many inquiries as to what can be reported as Annual PI training, here are a few examples:

For more details, … Full Story>

New Endocrine Clinical Research Group

-

The Endocrine Clinical Research Group has recently been created, with Dr. Pamela Kunz serving as the CRG leader and Ben Priestley as the Clinical Research Manager. The GI Neuroendocrine flowchart has now moved to the Endocrine group, and several other new flowcharts have been created.

You can view the PSOS documents and flowcharts for the Endocrine group at the following link: http://med.stanford.edu/cancer/research/trial-support/src/research-groups.html

For any questions regarding the Endocrine CRG please contact Ben.

SRC Updates – August 2017

-

The following study types no longer require SRC Renewal:

  • Pediatric studies,
  • Rare disease studies, and
  • Non-interventional studies.

Coordinators do not need to submit Renewal Protocol Statements of Support (PSOS) for these studies.

You will no longer receive a signed hard copy of SRC approval/renewal letters. The email notification from SRC-office will be the only communication moving forward.

For information on how to verify whether your study is a rare disease or non-interventional, … Full Story>